1. Dougados, M, Baeten, D. Spondyloarthritis. Lancet 2011; 377: 2127–2137.
Google Scholar | Crossref | Medline | ISI2. López Medina, C, Molto, A. Comorbidity management in spondyloarthritis. RMD Open 2020; 6: e001135.
Google Scholar | Crossref3. Moltó, A, Etcheto, A, van der Heijde, D, et al. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 2016; 75: 1016–1023.
Google Scholar | Crossref | Medline4. Exarchou, S, Lie, E, Lindström, U, et al. Mortality in ankylosing spondylitis: results from a nationwide population-based study. Ann Rheum Dis 2016; 75: 1466–1472.
Google Scholar | Crossref | Medline5. Oliveira Mde, F, Rocha Bde, O, Duarte, GV. Psoriasis: classical and emerging comorbidities. An Bras Dermatol 2015; 90: 9–20.
Google Scholar | Crossref | Medline6. Gottlieb, AB, Dann, F. Comorbidities in patients with psoriasis. Am J Med 2009; 122: 1150–1150.
Google Scholar | Crossref | Medline | ISI7. Adami, G, Fassio, A, Rossini, M, et al. Osteoporosis in rheumatic diseases. Int J Mol Sci 2019; 20: 5867.
Google Scholar | Crossref8. Maas, F, Spoorenberg, A, van der Slik, BPG, et al. Clinical risk factors for the presence and development of vertebral fractures in patients with ankylosing spondylitis. Arthritis Care Res 2017; 69: 694–702.
Google Scholar | Crossref | Medline9. Briot, K, Durnez, A, Paternotte, S, et al. Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort. Ann Rheum Dis 2013; 72: 1914–1919.
Google Scholar | Crossref | Medline10. Ghozlani, I, Ghazi, M, Nouijai, A, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009; 44: 772–776.
Google Scholar | Crossref | Medline | ISI11. Millard, TP, Antoniades, L, Evans, AV, et al. Bone mineral density of patients with chronic plaque of psoriasis. Clin Exp Dermatol 2001; 26: 446–448.
Google Scholar | Crossref | Medline12. Bremander, A, Petersson, IF, Bergman, S, et al. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 2011; 63: 550–556.
Google Scholar | Crossref | Medline13. López-Medina, C, Jiménez-Gómez, Y, Moltó, A, et al. Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: an ancillary study of the ASASCOMOSPA project. Joint Bone Spine 2018; 85: 447–453.
Google Scholar | Crossref | Medline14. Garrett, S, Jenkinson, T, Kennedy, LG, et al. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 1994; 21: 2286–2291.
Google Scholar | Medline | ISI15. Lukas, C, Landewé, R, Sieper, J, et al. Assessment of SpondyloArthritis International SOCIETY. Development of an ASAS-endorsed Disease Activity Score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 18–24.
Google Scholar | Crossref | Medline | ISI16. Calin, A, Garrett, S, Whitelock, H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 1994; 21: 2281–2285.
Google Scholar | Medline | ISI17. Berry, JD, Lloyd-Jones, DM, Garside, DB, et al. Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J 2007; 154: 80–86.
Google Scholar | Crossref | Medline | ISI18. von Elm, E, Altman, DG, Egger, M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–1457.
Google Scholar | Crossref | Medline | ISI19. Hu, SC, Lan, CE. Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment. Int J Mol Sci 2017; 18: E2211.
Google Scholar | Crossref20. Jensen, P, Skov, L. Psoriasis and obesity. Dermatology 2016; 232: 633–639.
Google Scholar | Crossref | Medline21. Perez-Chada, LM, Merola, JF. Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol 2020; 214: 108397.
Google Scholar | Crossref | Medline22. Lin, YC, Dalal, D, Churton, S, et al. Relationship between metabolic syndrome and carotid intima media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res 2014; 66: 97–103.
Google Scholar | Crossref | Medline | ISI23. Kastelan, D, Kastelan, M, Massari, LP, et al. Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations. Med Hypotheses 2006; 67: 1403–1405.
Google Scholar | Crossref | Medline | ISI24. Taylor, W. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665–2673.
Google Scholar | Crossref | Medline25. Rudwaleit, M, van der Heijde, D, Landewé, R, et al. The development and assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 677–683.
Google Scholar26. López-Medina, C, Moltó, A, Dougados, M. Peripheral manifestations in spondyloarthritis and their effect: an ancillary analysis of the ASAS-COMOSPA study. J Rheumatol 2020; 47: 211–217.
Google Scholar | Crossref | Medline